Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
HeadsUp Presents: Dr. Taylor will discuss assessment and treatment of Early Onset (that is onset before age 18 years old) Schizophrenia Spectrum Disorders. He will also discuss age-dependent assessments and phrasing of questions when evaluating younger adolescents with psychosis spectrum symptoms.
Objectives:
Determine how long is an “adequate trial” of an antipsychotic medication before switching based on evidence from the Treatment of Early Onset Schizophrenia Spectrum Disorders Study (TEOSS) and other research.
Enumerate the risks and benefits of different antipsychotics in adolescents in terms of metabolic side effects – i.e. antipsychotic-related weight gain Understand different methods of how to assess sleep and circadian rhythm in adolescent and young adults with psychosis
Catherine (Cat) Conroy, M.Ed, Manager of HeadsUp
Neurodevelopment and Psychosis Section, Department of Psychiatry
Perelman School of Medicine, University of Pennsylvania
10th floor, Gates Pavilion, HUP
3400 Spruce Street, Rm. 10054, Philadelphia, PA 19104
headsuppaorg@gmail.com
We are available during standard business hours (Monday-Friday, 9am-5pm) to answer any questions you may have about our organization or to direct you to programs in Pennsylvania that can offer clinical help.
